ISPE Part 11 Risk Paper

The ISPE submitted this undated paper to FDA as input to FDA’s Drug GMP modernization effort. Some of the concepts in this paper may be helpful to those trying to implement a risk based approach to electronic records as suggested in FDA’s Part 11 Redirection and Draft Scope Guidance.

ISPE Part11 White Paper

Expand your access! Subscribe today!

Corporate Office

Partners located in the US (CA, FL, MA, MN, TN) and Italy.